Law and Economics of Personalized Medicine - Bosshard, Karin
Bisher 69,99 €**
64,99 €
versandkostenfrei*

inkl. MwSt.
**Früherer Preis
Sofort lieferbar
32 °P sammeln
    Broschiertes Buch

The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice.…mehr

Produktbeschreibung
The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice.
  • Produktdetails
  • Gesundheitsmanagement und Gesundheitsökonomik
  • Verlag: Springer Fachmedien Wiesbaden / Springer Gabler / Springer, Berlin
  • Artikelnr. des Verlages: 978-3-658-22073-0
  • 1st ed. 2018
  • Erscheinungstermin: Juli 2018
  • Englisch
  • Abmessung: 210mm x 148mm x 24mm
  • Gewicht: 604g
  • ISBN-13: 9783658220730
  • ISBN-10: 3658220732
  • Artikelnr.: 52409982
Autorenporträt
Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen.
Inhaltsangabe
Overview of terminologies used in the context of personalized medicine.- Description of personalized medicine's impact on the healthcare landscape.- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice.- Analysis of institutional barriers to the translation of personalized medicine in Switzerland.- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice.